City of Hope has introduced a novel generative AI platform, HopeLLM, that leverages extensive oncology data and advanced models to streamline patient onboarding, personalize clinical trial matching, and extract real-world data for research. This innovation aims to reduce administrative burdens on healthcare providers, accelerate research breakthroughs, and broaden access to top-tier cancer care. Simon Nazarian, Chief Digital and Technology Officer at City of Hope, highlighted AI’s role in transforming workloads and enabling personalized medicine.